These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1868042

  • 1. A naturally occurring 6-9-kilodalton interleukin-1 (IL-1) inhibitor prevents IL-1-mediated islet cytotoxicity but not IL-1-mediated suppression of insulin secretion.
    Kawahara DJ, Everts M, Buckingham B, Sandborg C, Berman M.
    J Immunother (1991); 1991 Jun; 10(3):182-8. PubMed ID: 1868042
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J.
    J Immunol; 1987 Dec 15; 139(12):4077-82. PubMed ID: 3320203
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
    Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML.
    Diabetes; 1987 Aug 15; 36(8):963-70. PubMed ID: 3297891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells.
    Hao W, Palmer JP.
    J Interferon Cytokine Res; 1995 Dec 15; 15(12):1075-81. PubMed ID: 8746789
    [Abstract] [Full Text] [Related]

  • 7. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
    Eizirik DL, Welsh N, Hellerström C.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):399-403. PubMed ID: 8432782
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
    Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J.
    Diabetes; 1994 Jun 15; 43(6):770-7. PubMed ID: 8194662
    [Abstract] [Full Text] [Related]

  • 11. Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells.
    Eizirik DL, Tracey DE, Bendtzen K, Sandler S.
    Autoimmunity; 1992 Jun 15; 12(2):127-33. PubMed ID: 1535517
    [Abstract] [Full Text] [Related]

  • 12. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S, Bendtzen K, Borg LA, Eizirik DL, Strandell E, Welsh N.
    Endocrinology; 1989 Mar 15; 124(3):1492-501. PubMed ID: 2521822
    [Abstract] [Full Text] [Related]

  • 13. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
    Buscema M, Vinci C, Gatta C, Rabuazzo MA, Vignen R, Purrello F.
    Metabolism; 1992 Mar 15; 41(3):296-300. PubMed ID: 1531861
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.
    Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML.
    J Clin Invest; 1990 Sep 15; 86(3):856-63. PubMed ID: 2203826
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
    Sjöholm A.
    FEBS Lett; 1991 Sep 09; 289(2):249-52. PubMed ID: 1655527
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP, Andersen NA, Nielsen K, Karlsen AE, Fantuzzi G, Eizirik DL, Dinarello CA, Mandrup-Poulsen T.
    Eur Cytokine Netw; 2000 Jun 09; 11(2):193-205. PubMed ID: 10903798
    [Abstract] [Full Text] [Related]

  • 17. An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells.
    Papaccio G, Nicoletti F, Pisanti FA, Galdieri M, Bendtzen K.
    Mol Med; 2002 Sep 09; 8(9):536-45. PubMed ID: 12456992
    [Abstract] [Full Text] [Related]

  • 18. Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans.
    Buschard K, Aaen K, Horn T, Van Damme J, Bendtzen K.
    Autoimmunity; 1990 Sep 09; 5(3):185-94. PubMed ID: 2129751
    [Abstract] [Full Text] [Related]

  • 19. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.
    Vinci C, Caltabiano V, Santoro AM, Rabuazzo AM, Buscema M, Purrello R, Rizzarelli E, Vigneri R, Purrello F.
    Diabetologia; 1995 Jan 09; 38(1):39-45. PubMed ID: 7744228
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.
    Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M.
    Science; 1986 Jun 20; 232(4757):1545-7. PubMed ID: 3086977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.